Search results for

Ken Mehlman, the political director for the George W. Bush White House, compares the right to marry to other fundamental rights conservatives embrace. He rounded up a group of 131 prominent Republicans to sign a legal brief that's at odds with the House GOP leadership and the party's platform.

Host Rachel Martin talks with Jim Daly, president and chief executive officer of Focus on the Family, about the shifting religious and political landscape on gay rights and same-sex marriage.

Michael McCutcheon draws sketches of C-SPAN's morning guests and posts them on his website. The 73-year-old retiree says he isn't particularly interested in the guests, but simply does it to occupy his morning hours.

Actor Chris O'Dowd could watch the classic romance Dirty Dancing a million times. "I didn't know what romance was until I saw Dirty Dancing," he says," and nothing has come close since."

Toms River: A Story of Science and Salvation traces the story of a New Jersey town plagued by two generations of toxic waste dumping. Its author, Dan Fagin, talks about the origins of dumping in Toms River and its legacy today.

Recent polls show 70 percent of those aged 18 to 32 favor same-sex marriage. But the topic isn't settled, and for many young people, especially young Republicans, the issue of gay marriage is still a stumbling block.

Goldman Sachs has invested $9.6 million in a new initiative for juvenile offenders in the New York City prison system. While the Department of Corrections needs the money, some wonder if private investment has a place in government agencies.

For the last 15 years, a group of hobbyists has been tracking the movement of currency across the country. Self-named "Georgers" — after the president on the $1 bill — log the date, location and condition of bills they've encountered, and even spread the money by traveling across the country.

When abiding fear takes over some kids' lives, they respond with anger and aggression that's not premeditated. One psychiatrist says he's finding profound relief for a particular subgroup of these children in experimental research with the anesthesia drug ketamine.

The U.S. Supreme Court hears arguments Monday in a case worth billions of dollars to pharmaceutical companies and American consumers. The issue is whether brand-name drug manufacturers may pay generic drug manufacturers to keep their cheaper products off the market.